StockData
RenovoRx, Inc. logo

RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.95−0.09 (-8.18%)

Close on Nov 16, 2026Market cap $43.09MP/E –Yield –

RenovoRx enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

RenovoRx's enterprise value was $45.57M on Nov 11, 2026, against $23.58M a year earlier. Over the last 5 years it ranged from -$272.24K to $77.61M, with a median of $16.88M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$45.57M+119.7%
2025Dec 31, 2025$20.75M-3.1%
2024Dec 31, 2024$21.40M+0.6%
2023Dec 29, 2023$21.26M+60.8%
2022Dec 30, 2022$13.22M-47.9%
2021Dec 31, 2021$25.39M–

More RenovoRx figures

See a number that looks wrong?